This inventor holds 2 USPTO granted patents. Top assignee: Chemagis Ltd.. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Liu Xing: Innovator in Pharmaceutical Processes
Introduction
Liu Xing is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the production of imatinib, a crucial medication used in cancer treatment. With a total of 2 patents, Liu's work exemplifies innovation and dedication to improving drug synthesis.
Latest Patents
Liu Xing's latest patents include a process for producing imatinib and its salts, such as imatinib mesylate. This process involves the reaction of 4-(4-methyl-piperazin-1-ylmethyl)-benzoic acid with N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine in the presence of a carboxylic acid coupling reagent. Additionally, he has developed a novel process for preparing imatinib using the precursor 2-chloro-4-(3-pyridyl)-pyrimidine. This alternative synthetic route improves the preparation of imatinib while avoiding the use of the toxic reagent cyanamide.
Career Highlights
Liu Xing is associated with Chemagis Ltd., where he continues to advance pharmaceutical research and development. His innovative approaches have garnered attention in the industry, showcasing his commitment to enhancing drug production processes.
Collaborations
Liu has collaborated with notable professionals in his field, including Michel Bekhazi and Lior Zelikovitch. These partnerships have contributed to the success of his projects and the advancement of pharmaceutical technologies.
Conclusion
Liu Xing's contributions to the field of pharmaceuticals, particularly through his innovative processes for producing imatinib, highlight his role as a key inventor in the industry. His work not only improves drug synthesis but also demonstrates the importance of innovation in healthcare.